July 25, 2011Archives of Internal Medicine
The Use of Dabigatran in Elderly Patients
Key result
Dabigatran etexilate use in elderly patients resulted in severe bleeding events in two clinical cases, including one fatality, highlighting the risk of overdosage.
Why the study?
Does dabigatran etexilate increase the risk of bleeding events in elderly patients with atrial fibrillation?
Population
2 elderly patients with atrial fibrillation
Design
Case_series
Authors
Discussion
Loading...
Member takes
Implication
Supports caution with dabigatran dosing in elderly patients; leaves open need for prospective safety data.
Study Design
Type
Case Report (n=2)
Structured PICO
Does dabigatran etexilate increase the risk of bleeding events in elderly patients with atrial fibrillation?
P
Population
2 elderly patients receiving dabigatran etexilate who experienced bleeding events, including 1 fatal case.
E
Exposure
Dabigatran etexilate
O
Outcome
Bleeding eventssafety
Dabigatran use in elderly patients carries a significant risk of major bleeding and overdosage due to age-related factors such as renal impairment and low body weight.
Cite This Study
Matthieu Legrand (2011) conducted a case report in Atrial fibrillation (n=2). Dabigatran etexilate was evaluated on Bleeding events. Dabigatran etexilate use in elderly patients resulted in severe bleeding events in two clinical cases, including one fatality, highlighting the risk of overdosage.